These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29394101)

  • 1. Risperidone Treatment for Irritability in Fragile X Syndrome.
    Dominick KC; Wink LK; Pedapati EV; Shaffer R; Sweeney JA; Erickson CA
    J Child Adolesc Psychopharmacol; 2018 May; 28(4):274-278. PubMed ID: 29394101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Retrospective Naturalistic Study of Ziprasidone for Irritability in Youth with Autism Spectrum Disorder.
    Dominick K; Wink LK; McDougle CJ; Erickson CA
    J Child Adolesc Psychopharmacol; 2015 Jun; 25(5):397-401. PubMed ID: 26091194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label trial of risperidone in children and adolescents with severe mood dysregulation.
    Krieger FV; Pheula GF; Coelho R; Zeni T; Tramontina S; Zeni CP; Rohde LA
    J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):237-43. PubMed ID: 21663426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic Interventions for Irritability, Aggression, Agitation and Self-Injurious Behavior in Fragile X Syndrome: An Initial Cross-Sectional Analysis.
    Eckert EM; Dominick KC; Pedapati EV; Wink LK; Shaffer RC; Andrews H; Choo TH; Chen C; Kaufmann WE; Tartaglia N; Berry-Kravis EM; Erickson CA
    J Autism Dev Disord; 2019 Nov; 49(11):4595-4602. PubMed ID: 31468273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical trial of efficacy and safety.
    Nikoo M; Radnia H; Farokhnia M; Mohammadi MR; Akhondzadeh S
    Clin Neuropharmacol; 2015; 38(1):11-7. PubMed ID: 25580916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body mass index change in autism spectrum disorders: comparison of treatment with risperidone and aripiprazole.
    Wink LK; Early M; Schaefer T; Pottenger A; Horn P; McDougle CJ; Erickson CA
    J Child Adolesc Psychopharmacol; 2014 Mar; 24(2):78-82. PubMed ID: 24564519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin as an Adjunctive Therapy to Risperidone in Treatment of Autism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Moazen-Zadeh E; Shirzad F; Karkhaneh-Yousefi MA; Khezri R; Mohammadi MR; Akhondzadeh S
    J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):82-89. PubMed ID: 28719227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. l-Carnosine As an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Hajizadeh-Zaker R; Ghajar A; Mesgarpour B; Afarideh M; Mohammadi MR; Akhondzadeh S
    J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):74-81. PubMed ID: 29027815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder.
    Monnelly EP; Ciraulo DA; Knapp C; Keane T
    J Clin Psychopharmacol; 2003 Apr; 23(2):193-6. PubMed ID: 12640221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone in children with autism and serious behavioral problems.
    McCracken JT; McGough J; Shah B; Cronin P; Hong D; Aman MG; Arnold LE; Lindsay R; Nash P; Hollway J; McDougle CJ; Posey D; Swiezy N; Kohn A; Scahill L; Martin A; Koenig K; Volkmar F; Carroll D; Lancor A; Tierney E; Ghuman J; Gonzalez NM; Grados M; Vitiello B; Ritz L; Davies M; Robinson J; McMahon D;
    N Engl J Med; 2002 Aug; 347(5):314-21. PubMed ID: 12151468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized double-blind placebo-controlled clinical trial of adjuvant buspirone for irritability in autism.
    Ghanizadeh A; Ayoobzadehshirazi A
    Pediatr Neurol; 2015 Jan; 52(1):77-81. PubMed ID: 25451017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania.
    Ouyang WC; Hsu MC; Yeh IN; Kuo CC
    Int J Psychiatry Clin Pract; 2012 Sep; 16(3):178-88. PubMed ID: 22404731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulforaphane as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled clinical trial.
    Momtazmanesh S; Amirimoghaddam-Yazdi Z; Moghaddam HS; Mohammadi MR; Akhondzadeh S
    Psychiatry Clin Neurosci; 2020 Jul; 74(7):398-405. PubMed ID: 32347624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine for Drug-Refractory Irritability in Individuals with Developmental Disability.
    Wink LK; Badran I; Pedapati EV; Sorensen R; Benton SC; Johnson MC; Wissel G; Erickson CA
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):843-846. PubMed ID: 26986554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loxapine add-on for adolescents and adults with autism spectrum disorders and irritability.
    Hellings JA; Reed G; Cain SE; Zhou X; Barth FX; Aman MG; Palaguachi GI; Mikhnev D; Teng R; Andridge R; Logan M; Butler MG; Han JC
    J Child Adolesc Psychopharmacol; 2015 Mar; 25(2):150-9. PubMed ID: 25782098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and tolerability of switching to aripiprazole from risperidone in subjects with autism spectrum disorders: a prospective open-label study.
    Ishitobi M; Kosaka H; Takahashi T; Yatuga C; Asano M; Tanaka Y; Ueno K; Okazaki R; Omori M; Hiratani M; Tomoda A; Wada Y
    Clin Neuropharmacol; 2013; 36(5):151-6. PubMed ID: 24045605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome.
    Berry-Kravis E; Sumis A; Hervey C; Nelson M; Porges SW; Weng N; Weiler IJ; Greenough WT
    J Dev Behav Pediatr; 2008 Aug; 29(4):293-302. PubMed ID: 18698192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.